Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

The MITF regulatory network in melanoma.

Chauhan JS. et al, (2022), Pigment cell & melanoma research

Reciprocal regulation of BRN2 and NOTCH1/2 signaling synergistically drives melanoma cell migration and invasion.

Fane ME. et al, (2021), The Journal of investigative dermatology

TBX2 controls a proproliferative gene expression program in melanoma.

Lu S. et al, (2021), Genes & development

TOP1 modulation during melanoma progression and in adaptative resistance to BRAF and MEK inhibitors

Oliveira ÉAD. et al, (2021), Pharmacological Research, 173, 105911 - 105911

TBX3 Promotes Melanoma Migration by Transcriptional Activation of ID1, which Prevents Activation of E-Cadherin by MITF.

Peres J. et al, (2021), The Journal of investigative dermatology, 141, 2250 - 2260.e2

MC1R Functions, Expression, and Implications for Targeted Therapy.

Guida S. et al, (2021), The Journal of investigative dermatology

BRN2 is a non-canonical melanoma tumor-suppressor.

Hamm M. et al, (2021), Nature communications, 12

Establishment of a fluorescent reporter of RNA-polymerase II activity to identify dormant cells.

Freter R. et al, (2021), Nature communications, 12

The protective role of MC1R in chromosome stability and centromeric integrity in melanocytes.

Li X. et al, (2021), Cell death discovery, 7

MITF induces escape from innate immunity in melanoma.

Sánchez-Del-Campo L. et al, (2021), Journal of experimental & clinical cancer research : CR, 40

Organotypic Models in Drug Development "Tumor Models and Cancer Systems Biology for the Investigation of Anticancer Drugs and Resistance Development".

de Oliveira ÉA. et al, (2021), 265, 269 - 301

Acriflavine, a Potent Inhibitor of HIF-1α, Disturbs Glucose Metabolism and Suppresses ATF4-Protective Pathways in Melanoma under Non-Hypoxic Conditions

Martí-Díaz R. et al, (2020), Cancers, 13, 102 - 102

The transcription factor NRF2 enhances melanoma malignancy by blocking differentiation and inducing COX2 expression.

Jessen C. et al, (2020), Oncogene, 39, 6841 - 6855

Tuning Transcription Factor Availability through Acetylation-Mediated Genomic Redistribution

Louphrasitthiphol P. et al, (2020), Molecular Cell, 79, 472 - 487.e10

Paradoxical activation of AMPK by glucose drives selective EP300 activity in colorectal cancer.

Gutiérrez-Salmerón M. et al, (2020), PLoS biology, 18

ABCB5 is activated by MITF and β‐catenin and is associated with melanoma differentiation

Louphrasitthiphol P. et al, (2020), Pigment Cell & Melanoma Research, 33, 112 - 118

Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity.

Vivas-García Y. et al, (2020), Molecular cell, 77, 120 - 137.e9

The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor.

Coe EA. et al, (2019), PLoS genetics, 15

MITF controls the TCA cycle to modulate the melanoma hypoxia response.

Louphrasitthiphol P. et al, (2019), Pigment cell & melanoma research, 32, 792 - 808

Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities.

Rambow F. et al, (2019), Genes & development, 33, 1295 - 1318

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?

In this section